Introduction
When it comes to improving health, in particular health-related quality of life (HRQoL) – which can be summarized as the value ascribed to a person’s life for the duration of that life, by the individual or society, as a result of his or her own health and determinants such as personal behavior, medical care, health policy [
1‐
3] - policymakers strive to evaluate the success of health policies, technologies, or interventions across different contexts. This can be challenging due to diverse demographic, economic and healthcare system-related factors, but also because HRQoL is subjective and dependent on values, beliefs, and cultural context [
1‐
3]. The most common way to perform this assessment is through economic evaluations (EE) and, in particular, cost-utility analysis, which often use quality-adjusted life years (QALYs) as outcome measures, a metric that considers both life expectancy and quality of life [
4]. Yet, economic evaluations and health technology assessments (HTAs), are typically time-consuming, costly, and require significant expertise. Consequently, it is not feasible to conduct an EE or HTA for every policy, intervention or technology. Health decision makers, however, often have access to previously published EEs or HTAs, though these are frequently from other jurisdictions. This requires assessing if and how results from another jurisdiction can apply locally — a process referred to as transferability, often also called generalizability [
1,
2]. Before undertaking a new EE or HTA, it’s essential to first examine available studies from other settings and consider their applicability – an approach that is especially useful for decision-makers facing budget or time constraints. Given the growing demand for evidence-informed decision-making, there is increased interest in evaluating the transferability of EEs and HTAs to adapt external findings for local use. In this context, transferability refers to the extent to which the effects, outcomes, and cost-effectiveness of a health technology, intervention or policy implemented in one setting, population, or context can be generalized, adapted, or applied to another setting, considering differences in population demographics, healthcare systems, and socio-economic factors [
1,
2].
Preference-based multi-attribute utility instruments (MAUIs), such as the EQ-5D, measure HRQoL and are preferred for estimating utilities in QALY calculations [
5]. The EQ-5D-5L, introduced in 2012, assesses HRQoL by asking respondents to assess their health across five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), with five levels of severity (1 - no problems to 5 - extreme problems), defining unique 3,125 health states. A value set derived from a representative sample of the population is then applied to the respondents’ choices in order to determine a utility index for each health profile (0, death, to 1, full health), allowing for the estimation of QALYs [
6]. The EuroQol Valuation Technology (EQ-VT) protocol ensures a consistent approach across studies [
7]. Since 2012, 31 national value sets for EQ-5D-5L which used EQ-VT have been published. Differences in value sets between countries may reflect true differences in health state preferences or between protocol versions [
8,
9]. Identifying groups with similar preference patterns can guide decision-makers in selecting candidate countries for health policy or intervention transferability. As previously stated, conducting full EE or HTAs can be very complex and may not always be feasible. Therefore, especially in early-stage policy or technology implementation decisions in the absence of detailed EEs, finding
a priori candidate countries may be a practical solution. As health preference patterns are key features related to health policy transferability [
1,
2], this study proposes a new way of identifying these countries based on a shared perspective on their population’s health preferences. This could reduce initial costs, offering a pragmatic approach to prioritize or preliminarily assess policies, technologies or interventions before investing in a full evaluation.
In fact, previous research has shown distinct preference patterns across countries, with some studies estimating common currency values for groups with shared characteristics [
8‐
14]. For instance, Roudijk et al. [
8] assessed national value sets based on the relative importance of EQ-5D-5L dimensions, the value scale length and the distribution of values over the scale, identifying three groups with distinct preference patterns: Asian, Eastern European and Western countries. Łaszewska et al. [
12] used literature-based attributes (culture/religion, linguistics, healthcare system and financing and sociodemographic aspects) to develop 5 groups of English-speaking, Nordic, Central-Western, Southern and Eastern European countries. Still, a key limitation of these studies is the predefined grouping of countries based on literature or
a priori concepts. As health preferences are crucial for transferability, considering similarities across countries is essential. While cross-country differences exist, the European Union (EU) presents a cohesive sociocultural background and governance structure, making it an ideal region for such an analysis. However, no study has assessed value set differences in the EU in a truly data-driven manner, including through cluster analysis, the most widely used data segmentation method [
15].Thus, this paper aims to identify clusters of countries with similar preference patterns based on published EQ-5D-5L value sets in the EU-27.
Discussion
Our findings reveal five distinct clusters of EU-27 countries based on EQ-5D-5L health preferences, which remain robust across sensitivity analyses, including simulated coefficient distributions. This quantitative assessment has significant implications for the transferability of health policies, interventions, or technologies, aiding policymakers in selecting suitable candidate countries. As mentioned earlier, conducting a full EE in each country is resource-intensive and may not always be feasible or necessary at preliminary stages of decision-making. In these cases, our approach provides a cost-effective alternative by allowing countries to reference health policy decisions made by other countries with similar health preference profiles, which can significantly reduce initial costs, offering a pragmatic approach to prioritize or preliminarily assess interventions before investing in a full evaluation. Additionally, clustering based on similar health preferences rather than geographical or cultural proximity enables countries within a cluster to collaborate on health policy and share resources and experiences in a way that may lead to more effective and aligned health policies/interventions.
Our results align with previous research, emphasizing substantial differences in EQ-5D value sets due to methodological and cultural distinctions [
11]. As previously mentioned, some studies segmented European countries based on predefined criteria like geography, demography, or politics. Roudijk et al. [
8] compared EQ-5D-5 L value sets based on the relative importance of the dimensions, the value scale length and the distribution of values over the scale, and identified three groupings of countries according to preference patterns: Asia, Eastern Europe and Western countries. On the other hand, Łaszewska et al. [
12] considered cultural and socioeconomic and demographic factors and found 5 groups of countries, namely English-speaking, Nordic, Central-Western, Southern and Eastern European. The 5 clusters we found in our main estimation are partially in line with these groups: Clusters “
Belgium, Netherlands, Germany and Sweden” (red), “
France and Spain” (yellow) and “
Denmark and Ireland” (blue) would generally correspond to the Western European and Nordic groups, cluster “
Poland and Romania” (purple) to Eastern Europe. On the other hand, cluster “
Hungary, Italy and Portugal” (green) is quite uncommon and challenges traditional classifications, suggesting the importance of cultural and socioeconomic factors [
30‐
32].
Consistent patterns in dimension rankings emerged, with symptomatic dimensions (PD and AD) consistently considered more important than functional dimensions (MO, UA and SC). This is line with Roudijk et al.’s findings for Western Europe and, conversely, the opposite pattern for Asian countries. They also found that Eastern European countries were somehow in between - prioritizing PD and MO, with SC, AD and UA following suit. This is partially in line with our results on the relative importance of dimensions for each cluster, as can be seen in the red (Western and Northern European countries) and purple (Eastern European countries) clusters - Table
2. It is interesting to note that both the green cluster (Southern and Central Europe countries) and the yellow cluster (France and Spain; Western and Southern European countries) – placed higher importance to PD and MO dimensions, highlighting the importance of cultural and socioeconomic factors in health preferences of these populations rather than traditional geographical divisions. The blue cluster (Denmark and Ireland) places higher importance to the AD dimension, in line with the literature [
33,
34]. It is important to note that Sweden is in a different cluster than Denmark, which can relate to differing perspectives regarding mental health but also differences in access and quality of care [
35]. The green cluster (Hungary, Italy and Portugal) has a different pattern, placing higher importance to MO, SC and UA dimensions, which can reflect true differing perspectives [
36] or issues regarding access to quality care, urban planning and built environment, which have been documented to impact quality of life in these countries [
37,
38].
Our results also showed significant heterogeneity in the importance of PD and AD dimensions across severity levels, both when comparing single dimension level 5 (extreme severity) and level 3 (moderate severity) issues and also when comparing the coefficient in reference to level 1 (no problems), underscoring the influence of cultural, socioeconomic, and healthcare system factors on health preferences. They also suggest a difference in how some countries value moderate vs. severe health problems. In the yellow cluster (France and Spain), the trend from level 2 through 4 seemed aligned with the other clusters, suggesting a similar behaviour to the other countries’ value sets when it comes to the impact of moderate to severe problems. However, the fact that there is no further deterioration from level 4 to level 5 in the yellow cluster, unlike in other groups, suggests that the mean value set derived in this group (and, hence, the original value sets) did not distinguish between the most severe levels of problems in terms of their impact on the overall health state utility score. This in clear contrast with other clusters where there is a noticeable decrease in the utility score when moving from level 4 to level 5. While this could be due to quality of care or societal differences in those countries [
39], it could also be attributable to the methodology used in deriving the original value sets themselves, and whether or not it manages to adequately capture these differences.
Roudijk and Łaszewska calculated aggregate value sets for identified groups, suggesting their use for regional decision-making when national sets are unavailable [
12]. Unlike studies by Sajjad et al. [
11] and Greiner et al. [
13], who calculated pan-European value sets, our approach builds on these previous results, highlighting variability within the EU and emphasizing the importance of considering regional differences for successful economic evaluations and health policy/intervention implementation.
Even though ours is the first study of its kind, to the best of our knowledge, one previous work has used cluster analysis to perform transferability assessment. A 2022 study from the OECD [
40] identified groups of countries with the greatest potential for successful transfer of a specific intervention based on predefined key success factors. This is an important and interesting perspective, but one which still relies on
a priori expert considerations to define the clusters, which presents limitations.
Overall, our findings add to the literature on comparing health preferences and transferability of economic evaluations by exploring health preferences of EU-27 countries’ populations and emphasizing the need to consider socioeconomic, demographic, and cultural factors. Recognizing the diversity of perspectives and simultaneously the common visions within the EU is crucial for decision-making and understanding the challenges and opportunities of European integration. Our results can inform the implementation of new health policies, interventions or technologies by identifying target populations for success, while simultaneously fostering closer collaboration between countries within the same cluster. Furthermore, our results also set the scene for future research to address gaps in available value sets in the EU, enabling better-informed policy transfer between jurisdictions and ultimately leading to more equitable health outcomes.
Strengths & Limitations
The data-driven nature of our study is a clear strength, avoiding pre-assumed groupings that might bias results, allowing for a more realistic understanding of differences and similarities within EU-27 value sets. The hierarchical agglomerative nested clustering method chosen enhances the study’s robustness compared to more common techniques.
One possible limitation of our study is the fact that the full value sets were not always publicly available, which meant regression model coefficients were used instead. However, this is a valid alternative, and clustering based on utility scores derived from full value sets should produce similar results to clustering based on the regression coefficients, given that both are rooted in the same models (linear and non-linear). Still, in order to address possible inaccuracies due to this fact, and despite good overall clustering structure, we conducted sensitivity analysis considering (1) uncertainty, and (2) alternative clustering techniques, like K-means clustering. The simulated coefficient distributions expanded the dataset pool to consider health states coefficients as distributions rather than single points, thus allowing for the inclusion of modelling and distributional uncertainty, and it does not alter the results obtained in the first-stage analysis in an important way. The K-means clustering algorithm assumes a pre-defined number of clusters, which can introduce bias in the process [
15]. An additional limitation is the fact that diagnosis tests for determining the optimal number of clusters in hierarchical agglomerative cluster analysis are not consensual. Despite that, the Elbow plot method remains the most commonly used technique to this end, and it consistently pointed to five as the ideal number of clusters. The fact that agglomerative coefficients were generally high, and very high for our preferred cluster structure (AC = 0.813), Dunn index values reflecting moderate separation and compactness of the clusters (0.78 in our preferred cluster structure), and that cluster composition remained globally consistent in all of these analyses are strengths of the study. In fact, these moderate results for the Dunn index may be attributable to the nature of the data used, regression coefficients with relatively low variability and values close to zero. However, data preprocessing techniques such as dimensionality reduction through Principal Component Analysis would be inappropriate as they would lose too much information and make cross-country patterns difficult to assess. Additionally, the other clustering technique tested (K-means) yielded identical results, which reinforces the confidence in our results.
The inclusion of older populations in nationally representative samples raises the issue of population structure composition influencing results, as preferences may differ across age groups. Updating value sets thus becomes crucial with changing population structures, ensuring the relevance of health preferences. It is also important to note that these results are specific to the HRQoL instrument used in the analyses – EQ-5D-5L – and that using another instrument could possibly lead to different results, as they reflect specific conceptual schemes. methodological frameworks and study sample compositions.
Finally, the study’s reliance on only 13 out of 27 EU countries’ value sets is a limitation, stressing the importance for future research to develop more national value sets for comprehensive analysis and decision-making in the EU. Although strategies such as studying the determinants of HRQoL can be a way to overcome missing countries, reapplying cluster analysis when more value sets are available would be useful as a policy tool.
Conclusion
Despite clear differences in preference patterns across the EU-27, we found five clusters of countries based on the EQ-5D-5L health preferences. These do not directly translate commonly used sub-regional definitions of Europe, suggesting that traditional geographical or political factors may be insufficient to fully capture the cultural values or socioeconomic aspects that contribute to these variety of perspectives on health preferences. These results are essential for the transferability of health policies, interventions or technologies, as they can guide decision makers on which countries could be best candidates, based on EQ-5D-5L value sets. This would be useful for efficient resource allocation in a transfer process in the EU, for the implementation of new interventions, technologies or policies in best-candidate countries and to foster closer collaboration on health policy decisions. While being ready to apply results in the studied countries such as for testing new policies or technologies (i.e., using case studies from different countries), future research is needed to assess national value sets for countries missing this information. In conclusion, EU countries share a common vision and values, but different perspectives and preferences emerge from this study which can inform improved health policies in the EU – thus, fully reflecting the official motto of the EU: “In varietate concordia” (“United in diversity”).
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.